<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7289747\results\search\disease\results.xml">
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="the COVID-19 resource centre remains active. Abstract The 2019-novel coronavirus" exact="disease" post="(COVID-19) is caused by SARS-CoV-2 is transmitted from human"/>
  <result pre="The elderly and people with underlying diseases are susceptible to" exact="infection" post="and prone to serious outcomes, which may be associated"/>
  <result pre="and prone to serious outcomes, which may be associated with" exact="acute" post="respiratory distress syndrome (ARDS) and cytokine storm. Due to"/>
  <result pre="prone to serious outcomes, which may be associated with acute" exact="respiratory" post="distress syndrome (ARDS) and cytokine storm. Due to the"/>
  <result pre="serious outcomes, which may be associated with acute respiratory distress" exact="syndrome" post="(ARDS) and cytokine storm. Due to the rapid increase"/>
  <result pre="and cytokine storm. Due to the rapid increase of SARS-CoV-2" exact="infections" post="and unavailability of antiviral therapeutic agents, developing an effective"/>
  <result pre="SARS-CoV-2 which is genetically similar to SARS-CoV and Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) is an enveloped, single and positive-stranded"/>
  <result pre="which is genetically similar to SARS-CoV and Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) is an enveloped, single and positive-stranded RNA"/>
  <result pre="12 putative open reading frames responsible for the synthesis of" exact="viral" post="structural and nonstructural proteins which are very similar to"/>
  <result pre="a large number of patients with the symptoms similar to" exact="pneumonia" post="with unknown cause were detected from the city of"/>
  <result pre="Further, the detailed sequence analysis of the sample taken from" exact="lower" post="respiratory tract of a patient revealed the existence of,"/>
  <result pre="the detailed sequence analysis of the sample taken from lower" exact="respiratory" post="tract of a patient revealed the existence of, a"/>
  <result pre="SARS-CoV-2 that was never been reported earlier in humans [5]." exact="Infections" post="with SARS-CoV-2 are now widespread around the globe and"/>
  <result pre="around the globe and are increasing exponentially every day. A" exact="total" post="of 6 million cases with SARS-CoV-2 infections have been"/>
  <result pre="every day. A total of 6 million cases with SARS-CoV-2" exact="infections" post="have been confirmed up to May 29th, 2020, and"/>
  <result pre="on its surface. Transmission of COVID-19 is mainly caused by" exact="respiratory" post="droplets, direct human to human contact and fecal to"/>
  <result pre="transmission might be also associated [10]. COVID-19 prominently affect the" exact="respiratory" post="tract (both lower and upper respiratory tract), with the"/>
  <result pre="also associated [10]. COVID-19 prominently affect the respiratory tract (both" exact="lower" post="and upper respiratory tract), with the initial symptoms of"/>
  <result pre="[10]. COVID-19 prominently affect the respiratory tract (both lower and" exact="upper" post="respiratory tract), with the initial symptoms of common cold,"/>
  <result pre="COVID-19 prominently affect the respiratory tract (both lower and upper" exact="respiratory" post="tract), with the initial symptoms of common cold, fever,"/>
  <result pre="cold, fever, dry cough, fatigue, nasal congestion, sore throat and" exact="diarrhea" post="to severe pneumonia, difficulty in breathing and ends with"/>
  <result pre="with the patient death [11]. The incubation period of the" exact="disease" post="is 14Â days and the time from onset of"/>
  <result pre="days and the time from onset of symptom to developing" exact="pneumonia" post="is 4Â days [10]. The reservoir hosts of the"/>
  <result pre="pneumonia is 4Â days [10]. The reservoir hosts of the" exact="disease" post="are bats and Himalayan palm civets [12] but the"/>
  <result pre="human coronaviruses (hCoVs) 229E, NL63, OC43, and HKU1 causing mild" exact="respiratory" post="flu like seasonal illnesses, however three strains (SARS-CoV, MERS-CoV,"/>
  <result pre="precisely predict the possible vaccine candidates to prevent against CoV" exact="infection" post="in the future [16]. Currently there is no specific"/>
  <result pre="T cell and B cell memory. In case of SARS-CoV" exact="infection" post="both humoral and cellular immune responses are crucial for"/>
  <result pre="and cellular immune responses are crucial for the clearance of" exact="infection" post="(Fig. 1 ). Recombinant virus vectors work in a"/>
  <result pre="that induces neutralizing antibody and T-cell immune responses against SARS-CoV" exact="infection" post="[19,20] making it an important target for vaccine development."/>
  <result pre="S protein encoding DNA vaccine elicited protective immunity against SARS-CoV" exact="infection" post="in a mouse model by inducing T cell and"/>
  <result pre="is recognized by a variety of cell surface, endosomal and" exact="cytosolic" post="innate immune receptors. Mammalian cells can sense foreign RNA"/>
  <result pre="generation of high magnitude long-lived antibodies [27]. 3 Vaccination strategies" exact="Viral" post="zoonosis had resulted into many disease epidemics in recent"/>
  <result pre="[27]. 3 Vaccination strategies Viral zoonosis had resulted into many" exact="disease" post="epidemics in recent years and emergence of new strains"/>
  <result pre="an ideal vaccine against SARS-CoV, includes inactivated virus vaccines, recombinant" exact="viral" post="vaccines, subunit vaccine, DNA vaccines and attenuated vaccines [32]."/>
  <result pre="cellular immune responses Unprotected naked mRNA alone is not very" exact="stable" post="thus requires highly efficient carriers to stabilize and pack"/>
  <result pre="B cell mediated immunity Require appropriate adjuvant; cost-effectiveness may vary;" exact="lower" post="immunogenicity [24,49,63,67] Recombinant vector vaccines Coronavirus proteins/glycoproteins expressed by"/>
  <result pre="[24,49,63,67] Recombinant vector vaccines Coronavirus proteins/glycoproteins expressed by attenuated adenovirus/poxvirus/Newcastle" exact="disease" post="virus Phase I (NCT03399578, NCT03615911) Quickly constructed; Efficient in"/>
  <result pre="elicit long-termed cell mediated and humoral immunity Restricted cloning ability," exact="limited" post="host range and pre-existent immunity; route of administration that"/>
  <result pre="Preclinical Persists for longer period of time, showcases the entire" exact="viral" post="antigens complement to the host immune system, efficient in"/>
  <result pre="Preclinical Rapid development; efficient in inducing immunity and protection against" exact="virus infection;" post="efficiently neutralizes induction of antibody; can be formulated with"/>
  <result pre="that encodes either plasmid DNA or RNA i.e. mRNA or" exact="viral" post="replicon, are used in the nucleic acid based approaches."/>
  <result pre="[33]. Besides this various other DNA vaccines including AIDS [34]," exact="malaria" post="and influenza [35] are also under human trial. DNA"/>
  <result pre="antibody responses, and lowered the replication of SARS-CoV in the" exact="respiratory" post="tract this manifested that protective efficacy to the S"/>
  <result pre="improved the gene expression of spike (S) protein by heterologous" exact="viral" post="RNA export elements and protection in mouse model [39],"/>
  <result pre="N-specific antibody response and Tc-cell activity [42,44], moreover a strong" exact="delayed-type hypersensitivity" post="(DTH) and CD8(+) CTL responses to N protein was"/>
  <result pre="antibody response and Tc-cell activity [42,44], moreover a strong delayed-type" exact="hypersensitivity" post="(DTH) and CD8(+) CTL responses to N protein was"/>
  <result pre="cellular immunity but also considerably reduced the titer of challenging" exact="vaccinia" post="virus against the cells expressing N protein [43]. In"/>
  <result pre="their efficacy in field conditions are quite unsatisfactory and have" exact="lower" post="immunogenicity [48], as compared to other vaccines such as"/>
  <result pre="approaches such as heterologous prime or boost with proteins, inactivated" exact="viral" post="vaccine candidates or viral vectors have been constructed [28,41,[49],"/>
  <result pre="prime or boost with proteins, inactivated viral vaccine candidates or" exact="viral" post="vectors have been constructed [28,41,[49], [50], [51]]. 3.1.2 m-RNA"/>
  <result pre="average takes, 16Â years as in the case from human" exact="papilloma" post="virus, to rotavirus. The development of a protein-based vaccine"/>
  <result pre="The mRNA vaccine manifests the immune responses similar to natural" exact="infection" post="and provides a short synthetic viral mRNA, which is"/>
  <result pre="the immune responses similar to natural infection and provides a" exact="short" post="synthetic viral mRNA, which is then used by the"/>
  <result pre="responses similar to natural infection and provides a short synthetic" exact="viral" post="mRNA, which is then used by the host to"/>
  <result pre="it can circumvent the hassle associated with the purification of" exact="viral" post="proteins that saves the time from months to years"/>
  <result pre="are under clinical trials. The National Institute of Allergy and" exact="Infectious" post="Disease (NIAID), USA in collaboration with Moderna have initiated"/>
  <result pre="under clinical trials. The National Institute of Allergy and Infectious" exact="Disease" post="(NIAID), USA in collaboration with Moderna have initiated a"/>
  <result pre="develop an mRNA vaccine called mRNA-1273 [53] which produces a" exact="stable" post="form of the SARS-CoV-2 spike protein (S). NIAID has"/>
  <result pre="cytoplasm, so the unprotected naked mRNA alone is not very" exact="stable" post="to be used as a prophylactic vaccine. Due to"/>
  <result pre="the side effects at the site of inoculation. Due to" exact="stable" post="conditions and definite fragments of pathogen, subunit vaccines achieve"/>
  <result pre="4 in MERS-CoV and ACE2 in SARS-CoV, followed by the" exact="viral" post="and host membrane fusion facilitated by the S2 segment."/>
  <result pre="virus and later fusion of membranes as well thereby counteracting" exact="infection" post="of virus [58]. S glycoprotein of SARS-CoV which is"/>
  <result pre="have been reported to produce serum neutralizing antibodies and protected" exact="African" post="green monkeys and mice challenged with SARS-CoV [24,63]. S-ectodomain"/>
  <result pre="antibody thus causing protection of the vaccinated mice to SARS-CoV" exact="infection" post="[64]. Besides this, S protein associated with SARS-CoV is"/>
  <result pre="that elicits antibodies that are not neutralizing. To prevent the" exact="infection" post="from SARS-CoV, with different genotypes RBD containing recombinant proteins"/>
  <result pre="protein plays an essential role in upholding the configuration of" exact="viral" post="envelope [71] and M protein carries out this by"/>
  <result pre="been reported [[74], [75], [76]], consequently providing protection subsequent to" exact="infection" post="in animals [77] therefore, this suggest that in vivo"/>
  <result pre="N protein of SARS-CoV-2 do not provide immunity to the" exact="infection" post="[81]. 3.3 Recombinant vector vaccines Recombinant vector vaccines can"/>
  <result pre="long time and can react to antigen-presenting cells directly. Also" exact="viral" post="proteins in such vaccines can act like adjuvant [83],"/>
  <result pre="of the development of SARS-coronavirus (SARS-CoV) vaccine for which various" exact="viral" post="vectors are genetically engineered to express SARS-CoV proteins in"/>
  <result pre="engineered to express SARS-CoV proteins in them. Adenovirus and modified" exact="vaccinia" post="virus Ankara (MVA) are the two most common viral"/>
  <result pre="modified vaccinia virus Ankara (MVA) are the two most common" exact="viral" post="vectors used in the development of SARS-CoV and MERS-CoV"/>
  <result pre="of the symptoms of human patients including fever, transmission by" exact="respiratory" post="route, discharge of virus from upper airways and lung"/>
  <result pre="including fever, transmission by respiratory route, discharge of virus from" exact="upper" post="airways and lung injuries [88,89]. When ferrets were primed"/>
  <result pre="with a different adenovirus from chimpanzee, a significant reduction in" exact="viral" post="load and other clinical symptoms was observed [90]. Targeting"/>
  <result pre="Targeting that serotype to which humans are naÃ¯ve is the" exact="focal" post="point of recent adenoviral constructs. For this Chimpanzee adenovirus"/>
  <result pre="ChAdOx1coding for S-protein of MERS-CoV [92]. But restricted cloning ability," exact="limited" post="host range [93] and pre-existent immunity against adenovirus in"/>
  <result pre="humoral immunity [83]. In a study, replication-compromised poxvirus vector, modified" exact="vaccinia" post="Ankara (MVA) strain, coding for SARS-CoV S protein, generate"/>
  <result pre="for SARS-CoV S protein, generate neutralizing antibody response and reduced" exact="viral" post="load in the upper airways of mice [63]. MVA"/>
  <result pre="generate neutralizing antibody response and reduced viral load in the" exact="upper" post="airways of mice [63]. MVA constructs expressing entire S"/>
  <result pre="protein expressing MVA in mice generated CD8+ cells [99]. 3.3.3" exact="Newcastle disease" post="virus vectored vaccines Newcastle disease virus (NDV) viral-vector contain"/>
  <result pre="expressing MVA in mice generated CD8+ cells [99]. 3.3.3 Newcastle" exact="disease" post="virus vectored vaccines Newcastle disease virus (NDV) viral-vector contain"/>
  <result pre="generated CD8+ cells [99]. 3.3.3 Newcastle disease virus vectored vaccines" exact="Newcastle disease" post="virus (NDV) viral-vector contain MERS-CoV S protein which generated"/>
  <result pre="CD8+ cells [99]. 3.3.3 Newcastle disease virus vectored vaccines Newcastle" exact="disease" post="virus (NDV) viral-vector contain MERS-CoV S protein which generated"/>
  <result pre="namely, persistent immunity against NDV, higher threat of pathogenesis, low" exact="viral" post="titer production, and possible carcinogenesis [101]. Since viral vector-based"/>
  <result pre="pathogenesis, low viral titer production, and possible carcinogenesis [101]. Since" exact="viral" post="vector-based vaccines could be quickly constructed and used without"/>
  <result pre="this epitope could be actively pursued for the development of" exact="viral" post="vector based vaccines. 3.4 Attenuated vaccines Historical evidences demonstrate"/>
  <result pre="pathogens as they have already proven in case of various" exact="bacterial" post="and viral pathogens [[103], [104], [105]]. It is an"/>
  <result pre="they have already proven in case of various bacterial and" exact="viral" post="pathogens [[103], [104], [105]]. It is an attractive approach"/>
  <result pre="responses similar to natural infection, without posing any risk of" exact="infection" post="and provides long lasting protective immunity. Development of a"/>
  <result pre="they persists for longer period of time, showcases the entire" exact="viral" post="antigens complement to the host immune system, deliver antigen"/>
  <result pre="attenuated vaccination is a promising approach in the field of" exact="viral infection," post="but the main difficulty is the reversion of the"/>
  <result pre="of homologous (SARS-CoV, Urbani) and heterologous (GD03) SARS-CoV in the" exact="respiratory" post="tract (both the upper and lower respiratory tract) [109]."/>
  <result pre="and heterologous (GD03) SARS-CoV in the respiratory tract (both the" exact="upper" post="and lower respiratory tract) [109]. Thus, deletion of the"/>
  <result pre="(GD03) SARS-CoV in the respiratory tract (both the upper and" exact="lower" post="respiratory tract) [109]. Thus, deletion of the structural E"/>
  <result pre="SARS-CoV in the respiratory tract (both the upper and lower" exact="respiratory" post="tract) [109]. Thus, deletion of the structural E gene"/>
  <result pre="live-attenuated vaccine against SARS-CoV. Moreover, nsp-1 gene deleted CoV mouse" exact="hepatitis" post="virus (MHV) has also been reported with high efficacy"/>
  <result pre="8a, 8b or 9b results in very little and no" exact="viral" post="replication during in-vitro and in vivo conditions [108,111]. However"/>
  <result pre="vaccines viz. budding pathogens in bulk (biosafety level 3) and" exact="complete" post="sterilization of the grown pathogens. Successful sterilization of SARS-CoV,"/>
  <result pre="was observed to provide resistance by ceasing the multiplication of" exact="pulmonary" post="SARS-CoV, however immunological responses are yet to be verified"/>
  <result pre="and was able to minimize the virus load in the" exact="pulmonary" post="tract of the mouse model [87]. However, there are"/>
  <result pre="SARS-CoV induced significant neutralizing antibody and reduced virus replication in" exact="respiratory" post="tract of ferrets [89]. Rhesus monkeys were also been"/>
  <result pre="are able to induce SARS-CoV specific neutralizing antibodies so inactivated" exact="viral" post="vaccines could also be evaluated as potential vaccine candidate"/>
  <result pre="Many countries are affected by the rapid outbreak of SAR-CoV-2" exact="infections" post="so there is an urgent need to develop a"/>
  <result pre="it induces neutralizing antibodies that prevent host cell attachment and" exact="infection" post="[[127], [128], [129]]. Further nucleic acid based vaccine, showed"/>
  <result pre="prophylactic SAR-CoV-2 vaccine by using several platforms including mRNA, DNA," exact="vaccinia" post="or adenoviral vector and recombinant protein [112,132]. In order"/>
  <result pre="pathogen causes diseases in some individuals and mild or no" exact="infection" post="in others. Further, the evaluation of immunity and long-term"/>
  <result pre="ChinaInt. J. Infect. Dis.91202026426631953166 3ZhuN.ZhangD.WangW.LiX.YangB.SongJ.ZhaoX.HuangB.ShiW.LuR.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N. Engl. J. Med.3828202072773331978945 4PerlmanS.Another Decade, Another"/>
  <result pre="their replication and pathogenesisMethods Mol. Biol.1282201512325720466 8BÃ¡rcenaM.OostergetelG.T.BartelinkW.FaasF.G.VerkleijA.RottierP.J.KosterA.J.BoschB.J.Cryo-electron tomography of mouse" exact="hepatitis" post="virus: insights into the structure of the coronavirionProc. Natl."/>
  <result pre="of the coronavirionProc. Natl. Acad. Sci.1062200958258719124777 9NeumanB.W.AdairB.D.YoshiokaC.QuispeJ.D.OrcaG.KuhnP.MilliganR.A.YeagerM.BuchmeierM.J.Supramolecular architecture of severe" exact="acute" post="respiratory syndrome coronavirus revealed by electron cryomicroscopyJ. Virol.801620067918792816873249 10GuanW.-j.NiZ.-y.HuY.LiangW.-h.OuC.-q.HeJ.-x.LiuL.ShanH.LeiC.-l.HuiD.Clinical"/>
  <result pre="the coronavirionProc. Natl. Acad. Sci.1062200958258719124777 9NeumanB.W.AdairB.D.YoshiokaC.QuispeJ.D.OrcaG.KuhnP.MilliganR.A.YeagerM.BuchmeierM.J.Supramolecular architecture of severe acute" exact="respiratory" post="syndrome coronavirus revealed by electron cryomicroscopyJ. Virol.801620067918792816873249 10GuanW.-j.NiZ.-y.HuY.LiangW.-h.OuC.-q.HeJ.-x.LiuL.ShanH.LeiC.-l.HuiD.Clinical Characteristics"/>
  <result pre="coronavirionProc. Natl. Acad. Sci.1062200958258719124777 9NeumanB.W.AdairB.D.YoshiokaC.QuispeJ.D.OrcaG.KuhnP.MilliganR.A.YeagerM.BuchmeierM.J.Supramolecular architecture of severe acute respiratory" exact="syndrome" post="coronavirus revealed by electron cryomicroscopyJ. Virol.801620067918792816873249 10GuanW.-j.NiZ.-y.HuY.LiangW.-h.OuC.-q.HeJ.-x.LiuL.ShanH.LeiC.-l.HuiD.Clinical Characteristics of"/>
  <result pre="coronavirus revealed by electron cryomicroscopyJ. Virol.801620067918792816873249 10GuanW.-j.NiZ.-y.HuY.LiangW.-h.OuC.-q.HeJ.-x.LiuL.ShanH.LeiC.-l.HuiD.Clinical Characteristics of Coronavirus" exact="Disease" post="2019 in ChinaN. Engl. J. Med.3821820201708172032109013 11PaulesC.I.MarstonH.D.FauciA.S.Coronavirus infections-more than"/>
  <result pre="12SaifL.J.Animal coronaviruses: what can they teach us about the severe" exact="acute" post="respiratory syndrome?Rev. Sci. Tech.23200464366015702725 13FisherD.HeymannD.Q&amp;amp;A: the novel coronavirus outbreak"/>
  <result pre="coronaviruses: what can they teach us about the severe acute" exact="respiratory" post="syndrome?Rev. Sci. Tech.23200464366015702725 13FisherD.HeymannD.Q&amp;amp;A: the novel coronavirus outbreak causing"/>
  <result pre="COVID-19BMC Med.1820201):1331898501 14BelouzardS.MilletJ.K.LicitraB.N.WhittakerG.R.Mechanisms of coronavirus cell entry mediated by the" exact="viral" post="spike proteinViruses420121011103322816037 15HilgenfeldR.From SARS to MERS: crystallographic studies on"/>
  <result pre="coronavirus HCoV-229EJ. Virol.77420032530253812551991 19QinC.WangJ.WeiQ.SheM.MarascoW.A.JiangH.TuX.ZhuH.RenL.GaoH.GuoL.An animal model of SARS produced by" exact="infection" post="of Macaca mulatta with SARS coronavirusThe Journal of Pathology:"/>
  <result pre="antigenic determinants in inactivated SARS-CoV vaccineVaccine242620065498550816725238 21TanW.G.JinH.T.WestE.E.Penaloza-MacMasterP.WielandA.ZillioxM.J.McElrathM.J.BarouchD.H.AhmedR.Comparative analysis of simian" exact="immunodeficiency" post="virus gag-specific effector and memory CD8+ T cells induced"/>
  <result pre="CD8+ T cells induced by different adenovirus vectorsJ. Virol.87320131359137223175355 22HumphreysI.R.SebastianS.Novel" exact="viral" post="vectors in infectious diseasesImmunology153120181928869761 23LiL.PetrovskyN.Molecular mechanisms for enhanced DNA"/>
  <result pre="induced by different adenovirus vectorsJ. Virol.87320131359137223175355 22HumphreysI.R.SebastianS.Novel viral vectors in" exact="infectious" post="diseasesImmunology153120181928869761 23LiL.PetrovskyN.Molecular mechanisms for enhanced DNA vaccine immunogenicityExpert Review"/>
  <result pre="immune cell trafficking and harbour an altered protein cargo in" exact="chronic" post="airway inflammationJ. Transl. Med.141201618127320496 28LauS.K.WooP.C.LiK.S.HuangY.TsoiH.W.WongB.H.WongS.S.LeungS.Y.ChanK.H.YuenK.Y.Severe acute respiratory syndrome coronavirus-like"/>
  <result pre="altered protein cargo in chronic airway inflammationJ. Transl. Med.141201618127320496 28LauS.K.WooP.C.LiK.S.HuangY.TsoiH.W.WongB.H.WongS.S.LeungS.Y.ChanK.H.YuenK.Y.Severe" exact="acute" post="respiratory syndrome coronavirus-like virus in Chinese horseshoe batsProc. Natl."/>
  <result pre="protein cargo in chronic airway inflammationJ. Transl. Med.141201618127320496 28LauS.K.WooP.C.LiK.S.HuangY.TsoiH.W.WongB.H.WongS.S.LeungS.Y.ChanK.H.YuenK.Y.Severe acute" exact="respiratory" post="syndrome coronavirus-like virus in Chinese horseshoe batsProc. Natl. Acad."/>
  <result pre="cargo in chronic airway inflammationJ. Transl. Med.141201618127320496 28LauS.K.WooP.C.LiK.S.HuangY.TsoiH.W.WongB.H.WongS.S.LeungS.Y.ChanK.H.YuenK.Y.Severe acute respiratory" exact="syndrome" post="coronavirus-like virus in Chinese horseshoe batsProc. Natl. Acad. Sci.1033920051404014045"/>
  <result pre="batsProc. Natl. Acad. Sci.1033920051404014045 29BaizeS.PannetierD.OestereichL.RiegerT.KoivoguiL.MagassoubaN.F.SoropoguiB.SowM.S.KeÃ¯taS.De ClerckH.TiffanyA.Emergence of Zaire Ebola virus" exact="disease" post="in GuineaN. Engl. J. Med.3711520141418142524738640 30RiskiH.HoviT.Coronavirus infections of man"/>
  <result pre="Zaire Ebola virus disease in GuineaN. Engl. J. Med.3711520141418142524738640 30RiskiH.HoviT.Coronavirus" exact="infections" post="of man associated with diseases other than the common"/>
  <result pre="diseases other than the common coldJ. Med. Virol.6319802592656262459 31ChanJ.F.LauS.K.ToK.K.ChengV.C.WooP.C.YuenK.Y.Middle East" exact="respiratory" post="syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseClin. Microbiol."/>
  <result pre="other than the common coldJ. Med. Virol.6319802592656262459 31ChanJ.F.LauS.K.ToK.K.ChengV.C.WooP.C.YuenK.Y.Middle East respiratory" exact="syndrome" post="coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseClin. Microbiol. Rev.282201546552225810418"/>
  <result pre="SARS coronavirus vaccines and application of processes to other emerging" exact="infectious" post="diseasesCurr. Immunol. Rev.122005185200 33MacGregorR.R.BoyerJ.D.UgenK.E.LacyK.E.GluckmanS.J.BagarazziM.L.ChattergoonM.A.BaineY.HigginsT.J.CiccarelliR.B.ConeyL.R.First human trial of a DNA-based"/>
  <result pre="human trial of a DNA-based vaccine for treatment of human" exact="immunodeficiency" post="virus type 1 infection: safety and host responseJ. Infect."/>
  <result pre="of a DNA-based vaccine for treatment of human immunodeficiency virus" exact="type 1" post="infection: safety and host responseJ. Infect. Dis.17811998921009652427 34Oâ€™ConnellR.J.KimJ.H.CoreyL.MichaelN.L.Human immunodeficiency"/>
  <result pre="type 1 infection: safety and host responseJ. Infect. Dis.17811998921009652427 34Oâ€™ConnellR.J.KimJ.H.CoreyL.MichaelN.L.Human" exact="immunodeficiency" post="virus vaccine trialsCold Spring Harb. Perspect. Med.22012a007351 35FerraroB.MorrowM.P.HutnickN.A.ShinT.H.LuckeC.E.WeinerD.B.Clinical applications"/>
  <result pre="a DNA vaccine against SARSDNA Cell Biol.2610200772172617665998 39CallendretB.LorinV.CharneauP.MarianneauP.ContaminH.BettonJ.M.van der WerfS.EscriouN.Heterologous" exact="viral" post="RNA export elements improve expression of severe acute respiratory"/>
  <result pre="der WerfS.EscriouN.Heterologous viral RNA export elements improve expression of severe" exact="acute" post="respiratory syndrome (SARS) coronavirus spike protein and protective efficacy"/>
  <result pre="WerfS.EscriouN.Heterologous viral RNA export elements improve expression of severe acute" exact="respiratory" post="syndrome (SARS) coronavirus spike protein and protective efficacy of"/>
  <result pre="viral RNA export elements improve expression of severe acute respiratory" exact="syndrome" post="(SARS) coronavirus spike protein and protective efficacy of DNA"/>
  <result pre="responses with DNA vaccines encoded different gene fragments of severe" exact="acute" post="respiratory syndrome coronavirus in BALB/c miceBiochem. Biophys. Res. Commun.3271200513013515629440"/>
  <result pre="with DNA vaccines encoded different gene fragments of severe acute" exact="respiratory" post="syndrome coronavirus in BALB/c miceBiochem. Biophys. Res. Commun.3271200513013515629440 41WangX.XuW.TongD.NiJ.GaoH.WangY.ChuY.LiP.YangX.XiongS.A"/>
  <result pre="DNA vaccines encoded different gene fragments of severe acute respiratory" exact="syndrome" post="coronavirus in BALB/c miceBiochem. Biophys. Res. Commun.3271200513013515629440 41WangX.XuW.TongD.NiJ.GaoH.WangY.ChuY.LiP.YangX.XiongS.A chimeric"/>
  <result pre="chimeric multi-epitope DNA vaccine elicited specific antibody response against severe" exact="acute" post="respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV"/>
  <result pre="multi-epitope DNA vaccine elicited specific antibody response against severe acute" exact="respiratory" post="syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in"/>
  <result pre="characterization of DNA vaccines targeting the nucleocapsid protein of severe" exact="acute" post="respiratory syndrome coronavirusJ. Virol.78920044638464515078946 44ZhaoP.CaoJ.ZhaoL.J.QinZ.L.KeJ.S.PanW.RenH.YuJ.G.QiZ.T.Immune responses against SARS-coronavirus nucleocapsid"/>
  <result pre="of DNA vaccines targeting the nucleocapsid protein of severe acute" exact="respiratory" post="syndrome coronavirusJ. Virol.78920044638464515078946 44ZhaoP.CaoJ.ZhaoL.J.QinZ.L.KeJ.S.PanW.RenH.YuJ.G.QiZ.T.Immune responses against SARS-coronavirus nucleocapsid protein"/>
  <result pre="DNA vaccines targeting the nucleocapsid protein of severe acute respiratory" exact="syndrome" post="coronavirusJ. Virol.78920044638464515078946 44ZhaoP.CaoJ.ZhaoL.J.QinZ.L.KeJ.S.PanW.RenH.YuJ.G.QiZ.T.Immune responses against SARS-coronavirus nucleocapsid protein induced"/>
  <result pre="by a DNA vaccine encoding a novel HLA-A* 0201 severe" exact="acute" post="respiratory syndrome coronavirus epitopeVaccine253220076070607717629360 47OkadaM.OkunoY.HashimotoS.KitaY.KanamaruN.NishidaY.TsunaiY.InoueR.NakataniH.FukamizuR.NamieY.Development of vaccines and passive"/>
  <result pre="a DNA vaccine encoding a novel HLA-A* 0201 severe acute" exact="respiratory" post="syndrome coronavirus epitopeVaccine253220076070607717629360 47OkadaM.OkunoY.HashimotoS.KitaY.KanamaruN.NishidaY.TsunaiY.InoueR.NakataniH.FukamizuR.NamieY.Development of vaccines and passive immunotherapy"/>
  <result pre="DNA vaccine encoding a novel HLA-A* 0201 severe acute respiratory" exact="syndrome" post="coronavirus epitopeVaccine253220076070607717629360 47OkadaM.OkunoY.HashimotoS.KitaY.KanamaruN.NishidaY.TsunaiY.InoueR.NakataniH.FukamizuR.NamieY.Development of vaccines and passive immunotherapy against"/>
  <result pre="2 is a functional receptor for the SARS coronavirusNature4266965200345045414647384 60BergerA.DrostenC.DoerrH.W.SturmerM.PreiserW.Severe" exact="acute" post="respiratory syndrome (SARS) - paradigm of an emerging viral"/>
  <result pre="is a functional receptor for the SARS coronavirusNature4266965200345045414647384 60BergerA.DrostenC.DoerrH.W.SturmerM.PreiserW.Severe acute" exact="respiratory" post="syndrome (SARS) - paradigm of an emerging viral infectionJ."/>
  <result pre="a functional receptor for the SARS coronavirusNature4266965200345045414647384 60BergerA.DrostenC.DoerrH.W.SturmerM.PreiserW.Severe acute respiratory" exact="syndrome" post="(SARS) - paradigm of an emerging viral infectionJ. Clin."/>
  <result pre="60BergerA.DrostenC.DoerrH.W.SturmerM.PreiserW.Severe acute respiratory syndrome (SARS) - paradigm of an emerging" exact="viral" post="infectionJ. Clin. Virol.2912004132214675864 61HeY.ZhouY.WuH.LuoB.ChenJ.LiW.JiangS.Identification of immunodominant sites on the"/>
  <result pre="61HeY.ZhouY.WuH.LuoB.ChenJ.LiW.JiangS.Identification of immunodominant sites on the spike protein of severe" exact="acute" post="respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics"/>
  <result pre="of immunodominant sites on the spike protein of severe acute" exact="respiratory" post="syndrome (SARS) coronavirus: implication for developing SARS diagnostics and"/>
  <result pre="immunodominant sites on the spike protein of severe acute respiratory" exact="syndrome" post="(SARS) coronavirus: implication for developing SARS diagnostics and vaccinesJ."/>
  <result pre="for developing SARS diagnostics and vaccinesJ. Immunol.173620044050405715356154 62WeingartlH.CzubM.CzubS.NeufeldJ.MarszalP.GrenJ.SmithG.JonesS.ProulxR.DeschambaultY.GrudeskiE.Immunization with modified" exact="vaccinia" post="virus Ankara-based recombinant vaccine against severe acute respiratory syndrome"/>
  <result pre="62WeingartlH.CzubM.CzubS.NeufeldJ.MarszalP.GrenJ.SmithG.JonesS.ProulxR.DeschambaultY.GrudeskiE.Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe" exact="acute" post="respiratory syndrome is associated with enhanced hepatitis in ferretsJ."/>
  <result pre="with modified vaccinia virus Ankara-based recombinant vaccine against severe acute" exact="respiratory" post="syndrome is associated with enhanced hepatitis in ferretsJ. Virol.78222004126721267615507655"/>
  <result pre="modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory" exact="syndrome" post="is associated with enhanced hepatitis in ferretsJ. Virol.78222004126721267615507655 63BishtH.RobertsA.VogelL.BukreyevA.CollinsP.L.MurphyB.R.SubbaraoK.MossB.Severe"/>
  <result pre="vaccine against severe acute respiratory syndrome is associated with enhanced" exact="hepatitis" post="in ferretsJ. Virol.78222004126721267615507655 63BishtH.RobertsA.VogelL.BukreyevA.CollinsP.L.MurphyB.R.SubbaraoK.MossB.Severe acute respiratory syndrome coronavirus spike"/>
  <result pre="syndrome is associated with enhanced hepatitis in ferretsJ. Virol.78222004126721267615507655 63BishtH.RobertsA.VogelL.BukreyevA.CollinsP.L.MurphyB.R.SubbaraoK.MossB.Severe" exact="acute" post="respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia"/>
  <result pre="is associated with enhanced hepatitis in ferretsJ. Virol.78222004126721267615507655 63BishtH.RobertsA.VogelL.BukreyevA.CollinsP.L.MurphyB.R.SubbaraoK.MossB.Severe acute" exact="respiratory" post="syndrome coronavirus spike protein expressed by attenuated vaccinia virus"/>
  <result pre="associated with enhanced hepatitis in ferretsJ. Virol.78222004126721267615507655 63BishtH.RobertsA.VogelL.BukreyevA.CollinsP.L.MurphyB.R.SubbaraoK.MossB.Severe acute respiratory" exact="syndrome" post="coronavirus spike protein expressed by attenuated vaccinia virus protectively"/>
  <result pre="63BishtH.RobertsA.VogelL.BukreyevA.CollinsP.L.MurphyB.R.SubbaraoK.MossB.Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated" exact="vaccinia" post="virus protectively immunizes miceProc. Natl. Acad. Sci.1011720046641664615096611 64LiJ.UlitzkyL.SilbersteinE.TaylorD.R.ViscidiR.Immunogenicity and"/>
  <result pre="Res. Commun.3252200444545215530413 66HeY.ZhuQ.LiuS.ZhouY.YangB.LiJ.JiangS.Identification of a critical neutralization determinant of severe" exact="acute" post="respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccinesVirology33412005748215749124"/>
  <result pre="Commun.3252200444545215530413 66HeY.ZhuQ.LiuS.ZhouY.YangB.LiJ.JiangS.Identification of a critical neutralization determinant of severe acute" exact="respiratory" post="syndrome (SARS)-associated coronavirus: importance for designing SARS vaccinesVirology33412005748215749124 67HeY.ZhouY.LiuS.KouZ.LiW.FarzanM.JiangS.Receptor-binding"/>
  <result pre="66HeY.ZhuQ.LiuS.ZhouY.YangB.LiJ.JiangS.Identification of a critical neutralization determinant of severe acute respiratory" exact="syndrome" post="(SARS)-associated coronavirus: importance for designing SARS vaccinesVirology33412005748215749124 67HeY.ZhouY.LiuS.KouZ.LiW.FarzanM.JiangS.Receptor-binding domain"/>
  <result pre="Res. Commun.34222004773781 68WangS.Te-huiW.C.SakhatskyyP.V.HuangS.LawrenceJ.M.CaoH.HuangX.LuS.Identification of two neutralizing regions on the severe" exact="acute" post="respiratory syndrome coronavirus spike glycoprotein produced from the mammalian"/>
  <result pre="Commun.34222004773781 68WangS.Te-huiW.C.SakhatskyyP.V.HuangS.LawrenceJ.M.CaoH.HuangX.LuS.Identification of two neutralizing regions on the severe acute" exact="respiratory" post="syndrome coronavirus spike glycoprotein produced from the mammalian expression"/>
  <result pre="68WangS.Te-huiW.C.SakhatskyyP.V.HuangS.LawrenceJ.M.CaoH.HuangX.LuS.Identification of two neutralizing regions on the severe acute respiratory" exact="syndrome" post="coronavirus spike glycoprotein produced from the mammalian expression systemJ."/>
  <result pre="the sera of convalescent casesVirology3242200425125615207612 70PangH.LiuY.HanX.XuY.JiangF.WuD.KongX.BartlamM.RaoZ.Protective humoral responses to severe" exact="acute" post="respiratory syndrome-associated coronavirus: implications for the design of an"/>
  <result pre="sera of convalescent casesVirology3242200425125615207612 70PangH.LiuY.HanX.XuY.JiangF.WuD.KongX.BartlamM.RaoZ.Protective humoral responses to severe acute" exact="respiratory" post="syndrome-associated coronavirus: implications for the design of an effective"/>
  <result pre="vaccineJ. Gen. Virol.851020043109311315448374 71SchoemanD.FieldingB.C.Coronavirus envelope protein: current knowledgeVirol. J.16120196931133031 72HogueB.G.MachamerC.E.Coronavirus" exact="Structural" post="Proteins and Virus Assembly2008American Society of Microbiology 73OlsenC.W.A review"/>
  <result pre="and Virus Assembly2008American Society of Microbiology 73OlsenC.W.A review of feline" exact="infectious" post="peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccinationVet."/>
  <result pre="Virus Assembly2008American Society of Microbiology 73OlsenC.W.A review of feline infectious" exact="peritonitis" post="virus: molecular biology, immunopathogenesis, clinical aspects, and vaccinationVet. Microbiol.361â€&quot;219931378236772"/>
  <result pre="biology, immunopathogenesis, clinical aspects, and vaccinationVet. Microbiol.361â€&quot;219931378236772 74StohlmanS.A.BergmannC.C.Van der VeenR.C.HintonD.R.Mouse" exact="hepatitis" post="virus-specific cytotoxic T lymphocytes protect from lethal infection without"/>
  <result pre="der VeenR.C.HintonD.R.Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal" exact="infection" post="without eliminating virus from the central nervous systemJ. Virol.69219956846947815531"/>
  <result pre="virus from the central nervous systemJ. Virol.69219956846947815531 75StohlmanS.A.KyuwaS.PoloJ.M.BradyD.LaiM.M.BergmannC.C.Characterization of mouse" exact="hepatitis" post="virus-specific cytotoxic T cells derived from the central nervous"/>
  <result pre="of mouse hepatitis virus-specific cytotoxic T cells derived from the" exact="central nervous system" post="of mice infected with the JHM strainJ. Virol.67121993705070598230429 76BootsA.M.KustersJ.G.Van"/>
  <result pre="Lett.74119918 77CollissonE.W.PeiJ.DzielawaJ.SeoS.H.Cytotoxic T lymphocytes are critical in the control of" exact="infectious" post="bronchitis virus in poultryDev. Comp. Immunol.242â€&quot;3200018720010717287 78EnjuanesL.SmerdouCristianCastillaJoaquÃ­nAntÃ³nInÃ©s M.TorresJuan M.SolaIsabelGolvanoJosÃ©SÃ¡nchezJose"/>
  <result pre="77CollissonE.W.PeiJ.DzielawaJ.SeoS.H.Cytotoxic T lymphocytes are critical in the control of infectious" exact="bronchitis" post="virus in poultryDev. Comp. Immunol.242â€&quot;3200018720010717287 78EnjuanesL.SmerdouCristianCastillaJoaquÃ­nAntÃ³nInÃ©s M.TorresJuan M.SolaIsabelGolvanoJosÃ©SÃ¡nchezJose M.PintadoBelÃ©nDevelopment"/>
  <result pre="virus in poultryDev. Comp. Immunol.242â€&quot;3200018720010717287 78EnjuanesL.SmerdouCristianCastillaJoaquÃ­nAntÃ³nInÃ©s M.TorresJuan M.SolaIsabelGolvanoJosÃ©SÃ¡nchezJose M.PintadoBelÃ©nDevelopment of" exact="Protection Against" post="Coronavirus Induced Diseases1995SpringerBoston, MA 79ZhengN.XiaR.YangC.YinB.LiY.DuanC.LiangL.GuoH.XieQ.Boosted expression of the SARS-CoV"/>
  <result pre="83RochaC.D.CaetanoB.C.MachadoA.V.BruÃ±a-RomeroO.Recombinant viruses as tools to induce protective cellular immunity against" exact="infectious" post="diseasesInt. Microbiol.722004839415248156 84ZakhartchoukA.N.ViswanathanS.MahonyJ.B.GauldieJ.BabiukL.A.Severe acute respiratory syndrome coronavirus nucleocapsid protein"/>
  <result pre="to induce protective cellular immunity against infectious diseasesInt. Microbiol.722004839415248156 84ZakhartchoukA.N.ViswanathanS.MahonyJ.B.GauldieJ.BabiukL.A.Severe" exact="acute" post="respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus"/>
  <result pre="induce protective cellular immunity against infectious diseasesInt. Microbiol.722004839415248156 84ZakhartchoukA.N.ViswanathanS.MahonyJ.B.GauldieJ.BabiukL.A.Severe acute" exact="respiratory" post="syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector"/>
  <result pre="protective cellular immunity against infectious diseasesInt. Microbiol.722004839415248156 84ZakhartchoukA.N.ViswanathanS.MahonyJ.B.GauldieJ.BabiukL.A.Severe acute respiratory" exact="syndrome" post="coronavirus nucleocapsid protein expressed by an adenovirus vector is"/>
  <result pre="SARS-associated coronavirus vaccine in monkeysLancet362939920031895189614667748 87SeeR.H.ZakhartchoukA.N.PetricM.LawrenceD.J.MokC.P.HoganR.J.RoweT.ZitzowL.A.KarunakaranK.P.HittM.M.GrahamF.L.PrevecL.MahonyJ.B.SharonC.AuperinT.C.RiniJ.M.TingleA.J.ScheifeleD.W.SkowronskiD.M.PatrickD.M.VossT.G.BabiukL.A.GauldieJ.RoperR.L.BrunhamR.C.FinlayB.B.Comparative evaluation of two severe" exact="acute" post="respiratory syndrome (SARS) vaccine candidates in mice challenged with"/>
  <result pre="coronavirus vaccine in monkeysLancet362939920031895189614667748 87SeeR.H.ZakhartchoukA.N.PetricM.LawrenceD.J.MokC.P.HoganR.J.RoweT.ZitzowL.A.KarunakaranK.P.HittM.M.GrahamF.L.PrevecL.MahonyJ.B.SharonC.AuperinT.C.RiniJ.M.TingleA.J.ScheifeleD.W.SkowronskiD.M.PatrickD.M.VossT.G.BabiukL.A.GauldieJ.RoperR.L.BrunhamR.C.FinlayB.B.Comparative evaluation of two severe acute" exact="respiratory" post="syndrome (SARS) vaccine candidates in mice challenged with SARS"/>
  <result pre="vaccine in monkeysLancet362939920031895189614667748 87SeeR.H.ZakhartchoukA.N.PetricM.LawrenceD.J.MokC.P.HoganR.J.RoweT.ZitzowL.A.KarunakaranK.P.HittM.M.GrahamF.L.PrevecL.MahonyJ.B.SharonC.AuperinT.C.RiniJ.M.TingleA.J.ScheifeleD.W.SkowronskiD.M.PatrickD.M.VossT.G.BabiukL.A.GauldieJ.RoperR.L.BrunhamR.C.FinlayB.B.Comparative evaluation of two severe acute respiratory" exact="syndrome" post="(SARS) vaccine candidates in mice challenged with SARS coronavirusJ."/>
  <result pre="88ChuYKAliG.D.JiaF.LiQ.KelvinD.CouchR.C. â€¦JonssonC.B.The SARS-CoV ferret model in an infectionâ€&quot;challenge studyVirology3741200815116318234270 89SeeR.H.PetricM.LawrenceD.J.MokC.P.Y.RoweT.ZitzowL.A.KarunakaranK.P.VossT.G.BrunhamR.C.GauldieJ.FinlayB.B.RoperR.L.Severe" exact="acute" post="respiratory syndrome vaccine efficacy in ferrets: whole killed virus"/>
  <result pre="â€¦JonssonC.B.The SARS-CoV ferret model in an infectionâ€&quot;challenge studyVirology3741200815116318234270 89SeeR.H.PetricM.LawrenceD.J.MokC.P.Y.RoweT.ZitzowL.A.KarunakaranK.P.VossT.G.BrunhamR.C.GauldieJ.FinlayB.B.RoperR.L.Severe acute" exact="respiratory" post="syndrome vaccine efficacy in ferrets: whole killed virus and"/>
  <result pre="SARS-CoV ferret model in an infectionâ€&quot;challenge studyVirology3741200815116318234270 89SeeR.H.PetricM.LawrenceD.J.MokC.P.Y.RoweT.ZitzowL.A.KarunakaranK.P.VossT.G.BrunhamR.C.GauldieJ.FinlayB.B.RoperR.L.Severe acute respiratory" exact="syndrome" post="vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored"/>
  <result pre="virus and adenovirus-vectored vaccinesJ. Gen. Virol.89Pt 920082136214618753223 90KobingerG.P.FigueredoJ.M.RoweT.ZhiY.GaoG.SanmiguelJ.C.BellP.WivelN.A.ZitzowL.A.FliederD.B.HoganR.J.WilsonJ.M.Adenovirus-based vaccine prevents" exact="pneumonia" post="in ferrets challenged with the SARS coronavirus and stimulates"/>
  <result pre="One72012e40385 92YongC.Y.OngH.K.YeapS.K.HoK.L.TanW.S.Recent advances in the vaccine development against Middle East" exact="respiratory" post="syndrome-coronavirusFront. Microbiol.102019178131428074 93ImlerJ.L.Adenovirus vectors as recombinant viral vaccinesVaccine13131995114311518578797 94Fausther-BovendoH.KobingerG.P.Pre-existing"/>
  <result pre="against Middle East respiratory syndrome-coronavirusFront. Microbiol.102019178131428074 93ImlerJ.L.Adenovirus vectors as recombinant" exact="viral" post="vaccinesVaccine13131995114311518578797 94Fausther-BovendoH.KobingerG.P.Pre-existing immunity against ad vectors: humoral, cellular, and"/>
  <result pre="innate response, whatâ€™s important?Human Vaccines &amp;amp; Immunotherapeutics101020142875288425483662 95SongFFuxR.ProvaciaL.B.VolzA.EickmannM.BeckerS. â€¦SutterG.Middle East" exact="respiratory" post="syndrome coronavirus spike protein delivered by modified vaccinia virus"/>
  <result pre="response, whatâ€™s important?Human Vaccines &amp;amp; Immunotherapeutics101020142875288425483662 95SongFFuxR.ProvaciaL.B.VolzA.EickmannM.BeckerS. â€¦SutterG.Middle East respiratory" exact="syndrome" post="coronavirus spike protein delivered by modified vaccinia virus Ankara"/>
  <result pre="â€¦SutterG.Middle East respiratory syndrome coronavirus spike protein delivered by modified" exact="vaccinia" post="virus Ankara efficiently induces virus-neutralizing antibodiesJournal of virology87212013119501195423986586 96VolzAKupkeA.SongF.JanyS.FuxR.Shams-EldinH."/>
  <result pre="virus-neutralizing antibodiesJournal of virology87212013119501195423986586 96VolzAKupkeA.SongF.JanyS.FuxR.Shams-EldinH. â€¦SutterG.Protective efficacy of recombinant modified" exact="vaccinia" post="virus Ankara delivering Middle East respiratory syndrome coronavirus spike"/>
  <result pre="efficacy of recombinant modified vaccinia virus Ankara delivering Middle East" exact="respiratory" post="syndrome coronavirus spike glycoproteinJournal of virology891620158651865626018172 97AlharbiNKPadron-RegaladoE.ThompsonC.P.KupkeA.WellsD.SloanM.A. â€¦BeckerS.ChAdOx1 and"/>
  <result pre="of recombinant modified vaccinia virus Ankara delivering Middle East respiratory" exact="syndrome" post="coronavirus spike glycoproteinJournal of virology891620158651865626018172 97AlharbiNKPadron-RegaladoE.ThompsonC.P.KupkeA.WellsD.SloanM.A. â€¦BeckerS.ChAdOx1 and MVA"/>
  <result pre="Candidate MVA-MERS-S2018 99VeitS.JanyS.FuxR.SutterG.VolzA.CD8+ T cells responding to the middle east" exact="respiratory" post="syndrome coronavirus nucleocapsid protein delivered by vaccinia virus MVA"/>
  <result pre="MVA-MERS-S2018 99VeitS.JanyS.FuxR.SutterG.VolzA.CD8+ T cells responding to the middle east respiratory" exact="syndrome" post="coronavirus nucleocapsid protein delivered by vaccinia virus MVA in"/>
  <result pre="the middle east respiratory syndrome coronavirus nucleocapsid protein delivered by" exact="vaccinia" post="virus MVA in miceViruses10122018718 100LiuR.WangJ.ShaoY.WangX.ZhangH.ShuaiL.BuZ.A recombinant VSV-vectored MERS-CoV vaccine"/>
  <result pre="in rhesus monkeys after single dose immunizationAntivir. Res.1502018303829246504 101UraT.OkudaK.ShimadaM.Developments in" exact="viral" post="vector-based vaccinesVaccines2201462464126344749 102JiangS.HillyerC.DuL.Neutralizing antibodies against SARS-CoV-2 and other human"/>
  <result pre="and safety of live attenuated persistent and rapidly cleared Mycobacterium" exact="tuberculosis" post="vaccine candidates in non-human primatesVaccine2734200747094717 104NakhasiH.L.ZhengD.CallahanL.DaveJ.R.LiuT.Y.Rubella virus: mechanism of"/>
  <result pre="analysis of Sabin-like poliovirus isolates in NigeriaJ. Virol.901201531733126468545 107DeDiegoM.L.Ã�lvarezE.AlmazÃ¡nF.RejasM.T.LamirandeE.RobertsA.ShiehW.J.ZakiS.R.SubbaraoK.EnjuanesL.A severe" exact="acute" post="respiratory syndrome coronavirus that lacks the E gene is"/>
  <result pre="of Sabin-like poliovirus isolates in NigeriaJ. Virol.901201531733126468545 107DeDiegoM.L.Ã�lvarezE.AlmazÃ¡nF.RejasM.T.LamirandeE.RobertsA.ShiehW.J.ZakiS.R.SubbaraoK.EnjuanesL.A severe acute" exact="respiratory" post="syndrome coronavirus that lacks the E gene is attenuated"/>
  <result pre="Sabin-like poliovirus isolates in NigeriaJ. Virol.901201531733126468545 107DeDiegoM.L.Ã�lvarezE.AlmazÃ¡nF.RejasM.T.LamirandeE.RobertsA.ShiehW.J.ZakiS.R.SubbaraoK.EnjuanesL.A severe acute respiratory" exact="syndrome" post="coronavirus that lacks the E gene is attenuated in"/>
  <result pre="attenuated in vitro and in vivoJ. Virol.81420071701171317108030 108DeDiegoM.L.PeweL.AlvarezE.RejasM.T.PerlmanS.EnjuanesL.Pathogenicity of severe" exact="acute" post="respiratory coronavirus deletion mutants in hACE-2 transgenic miceVirology3762200837938918452964 109LamirandeE.W.DeDiegoM.L.RobertsA.JacksonJ.P.AlvarezE.SheahanT.ShiehW.J.ZakiS.R.BaricR.EnjuanesL.SubbaraoK.A"/>
  <result pre="in vitro and in vivoJ. Virol.81420071701171317108030 108DeDiegoM.L.PeweL.AlvarezE.RejasM.T.PerlmanS.EnjuanesL.Pathogenicity of severe acute" exact="respiratory" post="coronavirus deletion mutants in hACE-2 transgenic miceVirology3762200837938918452964 109LamirandeE.W.DeDiegoM.L.RobertsA.JacksonJ.P.AlvarezE.SheahanT.ShiehW.J.ZakiS.R.BaricR.EnjuanesL.SubbaraoK.A live"/>
  <result pre="deletion mutants in hACE-2 transgenic miceVirology3762200837938918452964 109LamirandeE.W.DeDiegoM.L.RobertsA.JacksonJ.P.AlvarezE.SheahanT.ShiehW.J.ZakiS.R.BaricR.EnjuanesL.SubbaraoK.A live attenuated severe" exact="acute" post="respiratory syndrome coronavirus is immunogenic and efficacious in golden"/>
  <result pre="mutants in hACE-2 transgenic miceVirology3762200837938918452964 109LamirandeE.W.DeDiegoM.L.RobertsA.JacksonJ.P.AlvarezE.SheahanT.ShiehW.J.ZakiS.R.BaricR.EnjuanesL.SubbaraoK.A live attenuated severe acute" exact="respiratory" post="syndrome coronavirus is immunogenic and efficacious in golden Syrian"/>
  <result pre="in hACE-2 transgenic miceVirology3762200837938918452964 109LamirandeE.W.DeDiegoM.L.RobertsA.JacksonJ.P.AlvarezE.SheahanT.ShiehW.J.ZakiS.R.BaricR.EnjuanesL.SubbaraoK.A live attenuated severe acute respiratory" exact="syndrome" post="coronavirus is immunogenic and efficacious in golden Syrian hamstersJ."/>
  <result pre="implications for the rational design of coronavirus vaccinesPLoS Pathog.382007e10917696607 111YountB.RobertsR.S.SimsA.C.DemingD.FriemanM.B.SparksJ.DenisonM.R.DavisN.BaricR.S.Severe" exact="acute" post="respiratory syndrome coronavirus group-specific open reading frames encode nonessential"/>
  <result pre="for the rational design of coronavirus vaccinesPLoS Pathog.382007e10917696607 111YountB.RobertsR.S.SimsA.C.DemingD.FriemanM.B.SparksJ.DenisonM.R.DavisN.BaricR.S.Severe acute" exact="respiratory" post="syndrome coronavirus group-specific open reading frames encode nonessential functions"/>
  <result pre="the rational design of coronavirus vaccinesPLoS Pathog.382007e10917696607 111YountB.RobertsR.S.SimsA.C.DemingD.FriemanM.B.SparksJ.DenisonM.R.DavisN.BaricR.S.Severe acute respiratory" exact="syndrome" post="coronavirus group-specific open reading frames encode nonessential functions for"/>
  <result pre="cell cultures and miceJ. Virol.79232005149091492216282490 112AmanatF.KrammerF.SARS-CoV-2 vaccines: status reportImmunity524202058358932259480 113KamitaniW.NarayananK.HuangC.LokugamageK.IkegamiT.ItoN.KuboH.MakinoS.Severe" exact="acute" post="respiratory syndrome coronavirus nsp1 protein suppresses host gene expression"/>
  <result pre="cultures and miceJ. Virol.79232005149091492216282490 112AmanatF.KrammerF.SARS-CoV-2 vaccines: status reportImmunity524202058358932259480 113KamitaniW.NarayananK.HuangC.LokugamageK.IkegamiT.ItoN.KuboH.MakinoS.Severe acute" exact="respiratory" post="syndrome coronavirus nsp1 protein suppresses host gene expression by"/>
  <result pre="and miceJ. Virol.79232005149091492216282490 112AmanatF.KrammerF.SARS-CoV-2 vaccines: status reportImmunity524202058358932259480 113KamitaniW.NarayananK.HuangC.LokugamageK.IkegamiT.ItoN.KuboH.MakinoS.Severe acute respiratory" exact="syndrome" post="coronavirus nsp1 protein suppresses host gene expression by promoting"/>
  <result pre="host mRNA degradationProc. Natl. Acad. Sci. U. S. A.103342006128851289016912115 114ItoN.MosselE.C.NarayananK.PopovV.L.HuangC.InoueT.PetersC.J.MakinoS.Severe" exact="acute" post="respiratory syndrome coronavirus 3a protein is a viral structural"/>
  <result pre="mRNA degradationProc. Natl. Acad. Sci. U. S. A.103342006128851289016912115 114ItoN.MosselE.C.NarayananK.PopovV.L.HuangC.InoueT.PetersC.J.MakinoS.Severe acute" exact="respiratory" post="syndrome coronavirus 3a protein is a viral structural proteinJ."/>
  <result pre="degradationProc. Natl. Acad. Sci. U. S. A.103342006128851289016912115 114ItoN.MosselE.C.NarayananK.PopovV.L.HuangC.InoueT.PetersC.J.MakinoS.Severe acute respiratory" exact="syndrome" post="coronavirus 3a protein is a viral structural proteinJ. Virol.79520053182318615709039"/>
  <result pre="A.103342006128851289016912115 114ItoN.MosselE.C.NarayananK.PopovV.L.HuangC.InoueT.PetersC.J.MakinoS.Severe acute respiratory syndrome coronavirus 3a protein is a" exact="viral" post="structural proteinJ. Virol.79520053182318615709039 115SchaecherS.R.MackenzieJ.M.PekoszA.The ORF7b protein of severe acute"/>
  <result pre="a viral structural proteinJ. Virol.79520053182318615709039 115SchaecherS.R.MackenzieJ.M.PekoszA.The ORF7b protein of severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells"/>
  <result pre="viral structural proteinJ. Virol.79520053182318615709039 115SchaecherS.R.MackenzieJ.M.PekoszA.The ORF7b protein of severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and"/>
  <result pre="structural proteinJ. Virol.79520053182318615709039 115SchaecherS.R.MackenzieJ.M.PekoszA.The ORF7b protein of severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated"/>
  <result pre="virus-infected cells and incorporated into SARS-CoV particlesJ. Virol.812200771873117079322 116ShenS.LinP.S.ChaoY.C.ZhangA.YangX.LimS.G.HongW.TanY.J.The severe" exact="acute" post="respiratory syndrome coronavirus 3a is a novel structural proteinBiochem."/>
  <result pre="cells and incorporated into SARS-CoV particlesJ. Virol.812200771873117079322 116ShenS.LinP.S.ChaoY.C.ZhangA.YangX.LimS.G.HongW.TanY.J.The severe acute" exact="respiratory" post="syndrome coronavirus 3a is a novel structural proteinBiochem. Biophys."/>
  <result pre="and incorporated into SARS-CoV particlesJ. Virol.812200771873117079322 116ShenS.LinP.S.ChaoY.C.ZhangA.YangX.LimS.G.HongW.TanY.J.The severe acute respiratory" exact="syndrome" post="coronavirus 3a is a novel structural proteinBiochem. Biophys. Res."/>
  <result pre="Mol. Biol.454200811912619057880 119TakasukaN.FujiiH.TakahashiY.KasaiM.MorikawaS.ItamuraS.IshiiK.SakaguchiM.OhnishiK.OhshimaM.HashimotoS.OdagiriT.TashiroM.YoshikuraH.TakemoriT.Tsunetsugu-YokotaY.A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits" exact="systemic" post="humoral immunity in miceInt. Immunol.161020041423143015314040 120TangL.ZhuQ.QinE.YuM.DingZ.ShiH.ChengX.WangC.ChangG.ZhuQ.FangF.ChangH.LiS.ZhangX.ChenX.YuJ.WangJ.ChenZ.Inactivated SARS-CoV vaccine prepared"/>
  <result pre="strainVaccine232420053196320115837220 123StadlerK.RobertsA.BeckerS.VogelL.EickmannM.KolesnikovaL.KlenkH.D.MurphyB.RappuoliR.AbrignaniS.SubbaraoK.SARS vaccine protective in miceEmerg. Infect. Dis.11820051312131416110580 124DarnellM.E.PlantE.P.WatanabeH.ByrumR.St ClaireM.WardJ.M.TaylorD.R.Severe" exact="acute" post="respiratory syndrome coronavirus infection in vaccinated ferretsJ. Infect. Dis.196920071329133817922397"/>
  <result pre="123StadlerK.RobertsA.BeckerS.VogelL.EickmannM.KolesnikovaL.KlenkH.D.MurphyB.RappuoliR.AbrignaniS.SubbaraoK.SARS vaccine protective in miceEmerg. Infect. Dis.11820051312131416110580 124DarnellM.E.PlantE.P.WatanabeH.ByrumR.St ClaireM.WardJ.M.TaylorD.R.Severe acute" exact="respiratory" post="syndrome coronavirus infection in vaccinated ferretsJ. Infect. Dis.196920071329133817922397 125ZhouJ.WangW.ZhongQ.HouW.YangZ.XiaoS.Y.ZhuR.TangZ.WangY.XianQ.TangH.WenL.Immunogenicity,"/>
  <result pre="vaccine protective in miceEmerg. Infect. Dis.11820051312131416110580 124DarnellM.E.PlantE.P.WatanabeH.ByrumR.St ClaireM.WardJ.M.TaylorD.R.Severe acute respiratory" exact="syndrome" post="coronavirus infection in vaccinated ferretsJ. Infect. Dis.196920071329133817922397 125ZhouJ.WangW.ZhongQ.HouW.YangZ.XiaoS.Y.ZhuR.TangZ.WangY.XianQ.TangH.WenL.Immunogenicity, safety,"/>
  <result pre="in miceEmerg. Infect. Dis.11820051312131416110580 124DarnellM.E.PlantE.P.WatanabeH.ByrumR.St ClaireM.WardJ.M.TaylorD.R.Severe acute respiratory syndrome coronavirus" exact="infection" post="in vaccinated ferretsJ. Infect. Dis.196920071329133817922397 125ZhouJ.WangW.ZhongQ.HouW.YangZ.XiaoS.Y.ZhuR.TangZ.WangY.XianQ.TangH.WenL.Immunogenicity, safety, and protective"/>
  <result pre="and immunogenicity from a phase I trial of inactivated severe" exact="acute" post="respiratory syndrome coronavirus vaccineAntivir. Ther.12720071107111318018769 127Al-AmriS.S.AbbasA.T.SiddiqL.A.AlghamdiA.SankiM.A.Al-MuhannaM.K.AlhabbabR.Y.AzharE.I.LiX.HashemA.M.Immunogenicity of candidate MERS-CoV"/>
  <result pre="immunogenicity from a phase I trial of inactivated severe acute" exact="respiratory" post="syndrome coronavirus vaccineAntivir. Ther.12720071107111318018769 127Al-AmriS.S.AbbasA.T.SiddiqL.A.AlghamdiA.SankiM.A.Al-MuhannaM.K.AlhabbabR.Y.AzharE.I.LiX.HashemA.M.Immunogenicity of candidate MERS-CoV DNA"/>
  <result pre="from a phase I trial of inactivated severe acute respiratory" exact="syndrome" post="coronavirus vaccineAntivir. Ther.12720071107111318018769 127Al-AmriS.S.AbbasA.T.SiddiqL.A.AlghamdiA.SankiM.A.Al-MuhannaM.K.AlhabbabR.Y.AzharE.I.LiX.HashemA.M.Immunogenicity of candidate MERS-CoV DNA vaccines"/>
  <result pre="131MaruggiG.ZhangC.LiJ.UlmerJ.B.YuD.mRNA as a transformative technology for vaccine development to control" exact="infectious" post="diseasesMol. Ther.274201975777230803823 132ChenW.H.StrychU.HotezP.J.BottazziM.E.The SARS-CoV-2 vaccine pipeline: an overviewCurr. Trop."/>
 </snippets>
</snippetsTree>
